Key result
Angiotensin II restores fat mass but fails to rescue plasma Agt or blood pressure in liver-Agt deficiency.
Why the study?
Does increasing adipose tissue mass via high-fat diet with or without angiotensin II supplementation elevate plasma angiotensinogen levels and restore blood pressure in liver-specific angiotensinogen knockout mice?
Does increasing adipose tissue mass via high-fat diet with or without angiotensin II supplementation elevate plasma angiotensinogen levels and restore blood pressure in liver-specific angiotensinogen knockout mice?
Answers are grounded in this paper and cite their sources.
Adipocyte-derived angiotensinogen contributes negligibly to circulating plasma angiotensinogen levels and systemic blood pressure regulation compared to hepatocyte-derived angiotensinogen, indicating that obesity-induced hypertension occurs independently of adipose-secreted plasma angiotensinogen.
Recently, it has been reported that 25% of plasma angiotensinogen (Agt) is derived from fat. Meanwhile, liver-specific Agt knockout (KO) mice have markedly low plasma Agt, which may be due to reduced fat mass. To study the contribution of the fat to plasma Agt, we tested whether increasing fat mass can elevate plasma Agt and blood pressure in liver- Agt KO mice. Epididymal fat mass in liver- Agt KO mice fed a high-fat diet (HFD) was 4.1-fold larger than that in liver- Agt KO mice on a normal-fat diet (NFD). The liver- Agt KO mice on NFD were hypotensive with low levels of plasma Agt (on average, 0.11 vs 2.38 μg/ml). HFD slightly increased plasma Agt (0.17 μg/ml) without increase in blood pressure. To further increase fat mass, liver- Agt KO mice were fed HFD and simultaneously supplemented with low-dose angiotensin II and compared with control mice. Fat mass was comparable between the two groups. However, liver- Agt KO mice had uniformly low plasma Agt (0.09 vs 2.07 μg/ml) and systolic blood pressure (78±12 vs 111±6 mm Hg). In conclusion, adipocyte-derived Agt has essentially no contribution to the plasma concentration and no impact on blood pressure compared to liver-derived Agt.
No takes yet. Share an insight, caveat, or question.
Koizumi et al. (2016) studied Hypotension and plasma angiotensinogen deficiency in liver-specific angiotensinogen knockout mice (n=31). High-fat diet (HFD-60) with or without subcutaneous low-dose angiotensin II supplementation vs. Normal-fat diet (NFD, 12.0% fat by calorie) in liver-Agt KO and control Agt mice was evaluated on Plasma angiotensinogen (Agt) concentration (μg/ml) and systolic blood pressure (mm Hg) in Experiment 2 (p=<0.001). High-fat diet plus angiotensin II in liver-Agt KO mice normalized fat mass but left plasma Agt and SBP low.
Synapse has enriched 10 related papers. Consider them for comparative context: